drugset / Trial / NCT00807222
Effect of Vyvanse on Sleep in Children Aged 6-12 Years With Attention Deficit Hyperactivity Disorder (ADHD)
RandomizedParallel-groupTriple-blindTreatment
Summary
This study involves research to test how Vyvanse (study drug) affects sleep in 24 children aged 6 to 12 years who have ADHD. Vyvanse is approved by the FDA for the treatment ADHD of in children aged 6 to 12 years. The experimental part of this study is to determine how Vyvanse affects sleep.
Timeline
- Start
- 2008-04
- Primary completion
- 2008-08
- Completion
- 2008-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Lisdexamfetamine | Other / unclassified | 30 mg | Oral |
| Comparator | Lisdexamfetamine | Other / unclassified | 50 mg | Oral |
| Comparator | Lisdexamfetamine | Other / unclassified | 70 mg | Oral |